Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
PALATIN TECHNOLOGIES INC | Director | Common Stock | 36.1K | $76.4K | $2.12 | Jul 15, 2024 | Direct |
PALATIN TECHNOLOGIES INC | Director | Stock Option (Right to Buy) | 54.3K | Jul 15, 2023 | Direct | ||
Monte Rosa Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 22.1K | Jun 12, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PTN | PALATIN TECHNOLOGIES INC | Jul 15, 2024 | 2 | $0 | 4 | Jul 16, 2024 | Director |
GLUE | Monte Rosa Therapeutics, Inc. | Jun 12, 2024 | 1 | $0 | 4 | Jun 13, 2024 | Director |
GLUE | Monte Rosa Therapeutics, Inc. | Jul 25, 2023 | 1 | $0 | 4 | Jul 26, 2023 | Director |
GLUE | Monte Rosa Therapeutics, Inc. | Jul 25, 2023 | 0 | $0 | 3 | Jul 26, 2023 | Director |
PTN | PALATIN TECHNOLOGIES INC | Jun 20, 2023 | 2 | $0 | 4 | Jun 22, 2023 | Director |
PTN | PALATIN TECHNOLOGIES INC | Jun 22, 2022 | 2 | $0 | 4 | Jun 24, 2022 | Director |
PTN | PALATIN TECHNOLOGIES INC | Jun 22, 2021 | 2 | $0 | 4 | Jun 24, 2021 | Director |